J&J secures dismissal of whistleblower case over misuse of confidential info

Reuters | June 2, 2023

By Brendan Pierson (Reuters) – A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower lawsuit against Johnson & Johnson as a sanction for the plaintiffs’ misuse of confidential records they obtained through related litigation. The lawsuit, which accused J&J’s DePuy Orthopaedics unit of defrauding the federal government by marketing […]

Big Tobacco faces big EU counterfeit problem

Reuters | June 1, 2023

By Richa Naidu, Emma Pinedo and Emilio Parodi MADRID (Reuters) – Spanish police raided three clandestine tobacco factories early this year, seizing nearly 40 million euros ($44 million) worth of tobacco leaf and illicit cigarettes. At one, in the northern town of Alfaro, they found 10 Ukrainian workers, five of them war refugees, who’d been […]

AstraZeneca to leave leading U.S. drug lobby group

Reuters | May 16, 2023

By Maggie Fick LONDON (Reuters) -AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in advocacy at the state and federal level, the company said. AstraZeneca decided not to continue its membership after a recent assessment of whether it […]

Novavax raises doubts about ability to remain in business, shares fall

Reuters | February 28, 2023

By Michael Erman NEW YORK (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign, and its shares plunged more than 25%. The company said there is significant uncertainty around its 2023 revenue, […]

CVS digs into primary care with $9.5 billion Oak Street Health deal

Reuters | February 8, 2023

By Bhanvi Satija and Raghav Mahobe (Reuters) – CVS Health Corp will buy Oak Street Health Inc for about $9.5 billion in cash, joining rivals in adding primary care to its portfolio as pressure mounts on its health insurance business. Oak Street is losing money and not expected to contribute to CVS earnings for years, […]

Bayer under investor pressure to speed up CEO changeover

Reuters | January 31, 2023

By Patricia Weiss and Ludwig Burger FRANKFURT (Reuters) – A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace chief executive Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development […]

Paxlovid sales forecasts may change with Pfizer view on China

Reuters | January 30, 2023

By Manas Mishra and Michael Erman (Reuters) – Clarity from Pfizer Inc this week on whether China’s relaxation of its Zero-COVID policy and the surge in infections there will lead to a spike in demand for its antiviral Paxlovid could spur analysts to alter their 2023 sales forecasts for the treatment. China was an insignificant […]

GE HealthCare rises 8% in market debut, eyes small deals

Reuters | January 4, 2023

By Leroy Leo and Kannaki Deka (Reuters) -GE HealthCare Technologies Inc’s shares rose as much as 8.4% in their Nasdaq debut on Wednesday and its chief executive said the company was looking to do small acquisitions to boost its cardiology and oncology operations in the long term. The company, which was spun off from conglomerate […]

Reckitt expects U.S. infant formula shortage until spring

Reuters | December 2, 2022

By Richa Naidu LONDON (Reuters) -The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to “persist” until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil. Panicked parents had earlier this year emptied the baby […]